| Office | WIPO |
| Document type: | Patent |
| Inventor(s): | Ana Marisa Chudzinski-Tavassi; Marcio Falci; Durvanei Augusto Maria; Cleyson Valença Reis |
| Applicant: | Ana Marisa Chudzinski-Tavassi; Biolab Sanus Farmacêutica Ltda; Cleyson Valença Reis; Durvanei Augusto Maria; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Marcio Falci |
| Year: | 2006 |
| Application Number: | PCT/BR2006/000180 |
| IPC: | A61K 38/17 C12N 15/12 |
Abstract
The invention refers to pharmaceutical compositions and cosmetic compositions comprising a prophylactic or therapeutically effective quantity of at least one polypeptide substantially identical to Lopap (a lipocalin-related protein with prothrombin activating protease activity). The invention refers to the use of these compositions as modulators of cell death and anti-aging agents.
| FAPESP's process: | 02/05874-4 - Efeito de proteases (fibrinolíticos e ativadores de fatores da coagulação) obtidos de venenos animais sobre células endotelias (HUVECs) e plaquetas. |
| Grantee: | Márcio Fritzen |
| Principal Investigator: | Ana Marisa Chudzinski-Tavassi |
| Institution: | Instituto Butantan |
| Support Opportunities: | Scholarships in Brazil - Doctorate |